+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Plasma Protein Therapeutics Market Analysis 2019

  • ID: 4857810
  • Report
  • October 2019
  • Region: Global
  • 148 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Baxter
  • Biotest AG
  • CSL Behring
  • Grifols, S.A.
  • Kamada
  • MORE
The Global Plasma Protein Therapeutics market is expected to reach $38.99 billion by 2026 growing at a CAGR of 6.3% during the forecast period. Plasma proteins are extensively used in replacement therapies for the treatment of conditions, such as deficiency of a coagulation factor in the field of hemostasis. This deficiency can be genetic or can occur due to autoimmune disorder. It can also occur as a complication of cancer. Fibrinogen is used as replacement therapy for the treatment of hemorrhagic diathesis in diseases, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. Development of novel products that offer clinical benefits such as improved efficacy and easy sample plasma extraction techniques are expected to increase penetration of plasma proteins in the market.

Favourable reimbursement policies and improved standard of living have led to increased life expectancy, contributing to rise in geriatric population are driving the market growth. However, ageing is considered the greatest risk factor for the development of cardiovascular and neurological diseases.

Based on the Product, the Immunoglobulin (IG) segment is dominating the global plasma protein therapeutics market and is estimated to have a lucrative growth due to the approval of biologics for multiple indications, easy administration process and less treatment cost.

The key vendors mentioned are Abbott, Amgen Inc, Baxter, Bayer AG, Biotest AG, BPL, Chengdu Institute of Biology (CIB), China Biologic Products Holdings, Inc., CSL Behring, Eli Lilly and Company, Grifols, S.A., Hualan Bio, Kamada, Kedrion S.P.A, and LFB Group.

Products Covered:
  • Albumin
  • Alpha-1 Proteinase Inhibitors
  • C1-Esterase Inhibitors
  • Coagulation Factors
  • Hyperimmune Globulins
  • Immunoglobulin (IG)
  • Plasma-Derived Factor VIII
  • Plasma-Derived Factor IX
  • Polyvalent IVIG/SCIG
  • Other Products
Applications Covered:
  • Hemophilia
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Primary Immunodeficiency Disorder (PID)
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Other Applications
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Baxter
  • Biotest AG
  • CSL Behring
  • Grifols, S.A.
  • Kamada
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Plasma Protein Therapeutics Market, By Product
5.1 Introduction
5.2 Albumin
5.3 Alpha-1 Proteinase Inhibitors
5.4 C1-Esterase Inhibitors
5.5 Coagulation Factors
5.6 Hyperimmune Globulins
5.7 Immunoglobulin (IG)
5.8 Plasma-Derived Factor VIII
5.9 Plasma-Derived Factor IX
5.10 Polyvalent IVIG/SCIG
5.11 Other Products

6 Global Plasma Protein Therapeutics Market, By Application
6.1 Introduction
6.2 Hemophilia
6.3 Idiopathic Thrombocytopenic Purpura (ITP)
6.4 Primary Immunodeficiency Disorder (PID)
6.5 Secondary Immunodeficiency
6.6 Hereditary Angioedema
6.7 Other Applications

7 Global Plasma Protein Therapeutics Market, By Geography
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 South America
7.5 Middle East & Africa

8 Strategic Benchmarking

9 Vendors Landscape
9.1 Abbott
9.2 Amgen Inc
9.3 Baxter
9.4 Bayer AG
9.5 Biotest AG
9.6 BPL
9.7 Chengdu Institute of Biology (CIB)
9.8 China Biologic Products Holdings, Inc.
9.9 CSL Behring
9.10 Eli Lilly and Company
9.11 Grifols, S.A.
9.12 Hualan Bio
9.13 Kamada
9.14 Kedrion S.P.A
9.15 LFB Group

List of Data Tables
Table 1 Global Plasma Protein Therapeutics Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 3 Global Plasma Protein Therapeutics Market Outlook, By Albumin (2016-2026) ($MN)
Table 4 Global Plasma Protein Therapeutics Market Outlook, By Alpha-1 Proteinase Inhibitors (2016-2026) ($MN)
Table 5 Global Plasma Protein Therapeutics Market Outlook, By C1-Esterase Inhibitors (2016-2026) ($MN)
Table 6 Global Plasma Protein Therapeutics Market Outlook, By Coagulation Factors (2016-2026) ($MN)
Table 7 Global Plasma Protein Therapeutics Market Outlook, By Hyperimmune Globulins (2016-2026) ($MN)
Table 8 Global Plasma Protein Therapeutics Market Outlook, By Immunoglobulin (IG) (2016-2026) ($MN)
Table 9 Global Plasma Protein Therapeutics Market Outlook, By Plasma-Derived Factor VIII (2016-2026) ($MN)
Table 10 Global Plasma Protein Therapeutics Market Outlook, By Plasma-Derived Factor IX (2016-2026) ($MN)
Table 11 Global Plasma Protein Therapeutics Market Outlook, By Polyvalent IVIG/SCIG (2016-2026) ($MN)
Table 12 Global Plasma Protein Therapeutics Market Outlook, By Other Products (2016-2026) ($MN)
Table 13 Global Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 14 Global Plasma Protein Therapeutics Market Outlook, By Hemophilia (2016-2026) ($MN)
Table 15 Global Plasma Protein Therapeutics Market Outlook, By Idiopathic Thrombocytopenic Purpura (ITP) (2016-2026) ($MN)
Table 16 Global Plasma Protein Therapeutics Market Outlook, By Primary Immunodeficiency Disorder (PID) (2016-2026) ($MN)
Table 17 Global Plasma Protein Therapeutics Market Outlook, By Secondary Immunodeficiency (2016-2026) ($MN)
Table 18 Global Plasma Protein Therapeutics Market Outlook, By Hereditary Angioedema (2016-2026) ($MN)
Table 19 Global Plasma Protein Therapeutics Market Outlook, By Other Applications (2016-2026) ($MN)
Table 20 North America Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 21 North America Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 22 Europe Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 23 Europe Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 24 Asia Pacific Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 25 Asia Pacific Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 26 South America Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 27 South America Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 28 Middle East & Africa Plasma Protein Therapeutics Market Outlook, By Product (2016-2026) ($MN)
Table 29 Middle East & Africa Plasma Protein Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott
  • Amgen Inc
  • Baxter
  • Bayer AG
  • Biotest AG
  • BPL
  • Chengdu Institute of Biology (CIB)
  • China Biologic Products Holdings, Inc.
  • CSL Behring
  • Eli Lilly and Company
  • Grifols, S.A.
  • Hualan Bio
  • Kamada
  • Kedrion S.P.A
  • LFB Group
Note: Product cover images may vary from those shown
Adroll
adroll